Product NDC: | 0085-1741 |
Proprietary Name: | Cipro |
Non Proprietary Name: | ciprofloxacin |
Active Ingredient(s): | 2 mg/mL & nbsp; ciprofloxacin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-1741 |
Labeler Name: | Schering Plough Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019857 |
Marketing Category: | NDA |
Start Marketing Date: | 20090427 |
Package NDC: | 0085-1741-02 |
Package Description: | 200 mL in 1 BOTTLE, PLASTIC (0085-1741-02) |
NDC Code | 0085-1741-02 |
Proprietary Name | Cipro |
Package Description | 200 mL in 1 BOTTLE, PLASTIC (0085-1741-02) |
Product NDC | 0085-1741 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ciprofloxacin |
Dosage Form Name | SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090427 |
Marketing Category Name | NDA |
Labeler Name | Schering Plough Corporation |
Substance Name | CIPROFLOXACIN |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |